Evidence map›Paper›PMID 38808443›Full record

ArticleProceedings. Biological sciences2024

Melanopsin-mediated amplification of cone signals in the human visual cortex.

Prakash Adhikari, Samir Uprety, Beatrix Feigl, Andrew J Zele

Abstract read
In one paragraph

Article in Proceedings. Biological sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Prakash AdhikariCentre for Vision and Eye Research, Queensland University of Technology (QUT), Brisbane, Queensland 4059, Australia.ORCID 0000-0003-4834-8500
Samir UpretyCentre for Vision and Eye Research, Queensland University of Technology (QUT), Brisbane, Queensland 4059, Australia.
Beatrix FeiglCentre for Vision and Eye Research, Queensland University of Technology (QUT), Brisbane, Queensland 4059, Australia.ORCID 0000-0001-7198-7373
Andrew J ZeleCentre for Vision and Eye Research, Queensland University of Technology (QUT), Brisbane, Queensland 4059, Australia.ORCID 0000-0003-0291-9929

Funding

Australian Research Council Future Fellowship ARC-FT180100458 (A.J.Z.)
6 · The paper itself

Abstract

The ambient daylight variation is coded by melanopsin photoreceptors and their luxotonic activity increases towards midday when colour temperatures are cooler, and irradiances are higher. Although melanopsin and cone photoresponses can be mediated via separate pathways, the connectivity of melanopsin cells across all levels of the retina enables them to modify cone signals. The downstream effects of melanopsin-cone interactions on human vision are however, incompletely understood. Here, we determined how the change in daytime melanopsin activation affects the human cone pathway signals in the visual cortex. A 5-primary silent-substitution method was developed to evaluate the dependence of cone-mediated signals on melanopsin activation by spectrally tuning the lights and stabilizing the rhodopsin activation under a constant cone photometric luminance. The retinal (white noise electroretinogram) and cortical responses (visual evoked potential) were simultaneously recorded with the photoreceptor-directed lights in 10 observers. By increasing the melanopsin activation, a reverse response pattern was observed with cone signals being supressed in the retina by 27% (

Indexed as

Retinal Cone Photoreceptor CellsRod OpsinsVisual CortexAdultElectroretinographyEvoked Potentials, VisualFemaleHumansMaleMelanopsinPhotic StimulationYoung AdultMelanopsinRod Opsinsconeselectroretinogrammelanopsinvisionvisual evoked potentials

Identifiers

PMID38808443
PMCPMC11285915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.